If you need more lookups,
subscriptions start at $34 USD/month.
Borna Payandemehr Location
Istanbul, Turkey
Borna Payandemehr Work
Executive Board Member @ (January 2023 - Present)
Vice President, Business Development @ CinnaGen Pharmaceutical Group (December 2017 - January 2024)
Vice President, Business Development @ Singapore Biotech (January 2019 - December 2020)
Business Development Senior Manager @ (May 2016 - December 2017)
Technology Transfer Manager @ (May 2015 - February 2017)
Research Director @ (March 2013 - May 2015)
Research assistant @ Tehran University of Medical Sciences (May 2012 - March 2015)
Editorial Board Member @ journal of Pharmacologia (January 2013 - March 2014)
Borna Payandemehr Education
Tehran University of Medical Sciences
Doctor of Pharmacy (Pharm.D.)
2006-2012
Kamal High School
High School (Mathematics and Physics)
2002-2005
Borna Payandemehr Skills
Research design and proposal writing
Scientific Writing
Neuroscience
Neuropharmacology
Neuropsychopharmacology
Statistical Data Analysis
Animal Behavior
Psychopharmacology
Biotechnology
Life Sciences
Molecular Biology
Statistics
SPSS
Protein Purification
Technology Transfer
SOP
Biosimilars
Pharmaceutics
GMP
ISO
Chromatography
Science
Clinical Trials
Clinical Research
Research
Pharmaceutical Industry
Pharmacology
Healthcare
Social Media
Public Speaking
Editing
Microsoft Office
Sales
Strategy
Borna Payandemehr Summary
Borna Payandemehr, based in Istanbul, Turkey, is currently a Executive Board Member at Yerlika Biopharma. Borna Payandemehr brings experience from previous roles at CinnaGen Pharmaceutical Group, Singapore Biotech and CinnaGen. Borna Payandemehr holds a 2006 - 2012 Doctor of Pharmacy (Pharm.D.) @ Tehran University of Medical Sciences. With a robust skill set that includes Research design and proposal writing, Scientific Writing, Neuroscience, Neuropharmacology, Neuropsychopharmacology and more. Borna Payandemehr has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Borna Payandemehr?
Find contact details for 700 million professionals.